Tansel Özyer

Tansel Özyer

Auto-generated profile, based on publicly available information

Tansel Özyer

Department of Computer Engineering, Ankara Medipol University, Ankara, Turkey

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 February 2019 in BMC Research Notes
Verified
Journal Article
Open access
PDF file
AAAlper Aksac
Alper Aksac
DDDouglas J. Demetrick
Douglas J. Demetrick
TOTansel Ozyer
Tansel Ozyer
RAReda Alhajj
Reda Alhajj
Histopathological tissue analysis by a pathologist determines the diagnosis and prognosis of most tumors, such as breast cancer. To estimate the aggressiveness of cancer, a pathologist evaluates the microscopic appearance of a biopsied tissue sample based on morphological features which have been correlated with patient outcome. This paper introduces a dataset of 162 breast cancer histopathology images, namely the breast cancer histopathological annotation and diagnosis dataset (BreCaHAD) which allows researchers to optimize and evaluate the usefulness of their proposed methods. The dataset includes various malignant cases. The task associated with this dataset is to automatically classify histological structures in these hematoxylin and eosin (H&E) stained images into six classes, namely mitosis, apoptosis, tumor nuclei, non-tumor nuclei, tubule, and non-tubule. By providing this dataset to the biomedical imaging community, we hope to encourage researchers in computer vision, machine learning and medical fields to contribute and develop methods/tools for automatic detection and diagnosis of cancerous regions in breast cancer histology images.

1 June 2021 in Knowledge-Based Systems
Verified
Journal Article
Closed access
TÖTansel Özyer
Tansel Özyer
DADuygu Selin Ak
Duygu Selin Ak
RAReda Alhajj
Reda Alhajj

28 January 2023 in Medical & Biological Engineering & Computing
Verified
Journal Article
Open access
PDF file
KSKashfia Sailunaz
Kashfia Sailunaz
TÖTansel Özyer
Tansel Özyer
JRJon Rokne
Jon Rokne
RAReda Alhajj
Reda Alhajj
The ongoing COVID-19 pandemic caused by the SARS-CoV-2 virus has already resulted in 6.6 million deaths with more than 637 million people infected after only 30 months since the first occurrences of the disease in December 2019. Hence, rapid and accurate detection and diagnosis of the disease is the first priority all over the world. Researchers have been working on various methods for COVID-19 detection and as the disease infects lungs, lung image analysis has become a popular research area for detecting the presence of the disease. Medical images from chest X-rays (CXR), computed tomography (CT) images, and lung ultrasound images have been used by automated image analysis systems in artificial intelligence (AI)- and machine learning (ML)-based approaches. Various existing and novel ML, deep learning (DL), transfer learning (TL), and hybrid models have been applied for detecting and classifying COVID-19, segmentation of infected regions, assessing the severity, and tracking patient progress from medical images of COVID-19 patients. In this paper, a comprehensive review of some recent approaches on COVID-19-based image analyses is provided surveying the contributions of existing research efforts, the available image datasets, and the performance metrics used in recent works. The challenges and future research scopes to address the progress of the fight against COVID-19 from the AI perspective are also discussed. The main objective of this paper is therefore to provide a summary of the research works done in COVID detection and analysis from medical image datasets using ML, DL, and TL models by analyzing their novelty and efficiency while mentioning other COVID-19-based review/survey researches to deliver a brief overview on the maximum amount of information on COVID-19-based existing researches.

26 April 2016 in BMC Research Notes
Verified
Journal Article
Open access
PDF file
GJGabriela Jurca
Gabriela Jurca
OAOmar Addam
Omar Addam
AAAlper Aksac
Alper Aksac
SGShang Gao
Shang Gao
TÖTansel Özyer
Tansel Özyer
RAReda Alhajj
Reda Alhajj
Breast cancer is a serious disease which affects many women and may lead to death. It has received considerable attention from the research community. Thus, biomedical researchers aim to find genetic biomarkers indicative of the disease. Novel biomarkers can be elucidated from the existing literature. However, the vast amount of scientific publications on breast cancer make this a daunting task. This paper presents a framework which investigates existing literature data for informative discoveries. It integrates text mining and social network analysis in order to identify new potential biomarkers for breast cancer. We utilized PubMed for the testing. We investigated gene–gene interactions, as well as novel interactions such as gene-year, gene-country, and abstract-country to find out how the discoveries varied over time and how overlapping/diverse are the discoveries and the interest of various research groups in different countries. Interesting trends have been identified and discussed, e.g., different genes are highlighted in relationship to different countries though the various genes were found to share functionality. Some text analysis based results have been validated against results from other tools that predict gene–gene relations and gene functions.

12 April 2018 in BMC Bioinformatics
Verified
Journal Article
Open access
PDF file
MOMakbule Guclin Ozsoy
Makbule Guclin Ozsoy
TÖTansel Özyer
Tansel Özyer
FPFaruk Polat
Faruk Polat
RAReda Alhajj
Reda Alhajj
Drug repositioning is the process of identifying new targets for known drugs. It can be used to overcome problems associated with traditional drug discovery by adapting existing drugs to treat new discovered diseases. Thus, it may reduce associated risk, cost and time required to identify and verify new drugs. Nowadays, drug repositioning has received more attention from industry and academia. To tackle this problem, researchers have applied many different computational methods and have used various features of drugs and diseases. In this study, we contribute to the ongoing research efforts by combining multiple features, namely chemical structures, protein interactions and side-effects to predict new indications of target drugs. To achieve our target, we realize drug repositioning as a recommendation process and this leads to a new perspective in tackling the problem. The utilized recommendation method is based on Pareto dominance and collaborative filtering. It can also integrate multiple data-sources and multiple features. For the computation part, we applied several settings and we compared their performance. Evaluation results show that the proposed method can achieve more concentrated predictions with high precision, where nearly half of the predictions are true. Compared to other state of the art methods described in the literature, the proposed method is better at making right predictions by having higher precision. The reported results demonstrate the applicability and effectiveness of recommendation methods for drug repositioning.

25 June 2019 in Pattern Recognition
Verified
Journal Article
Closed access
AAAlper Aksac
Alper Aksac
TÖTansel Özyer
Tansel Özyer
RAReda Alhajj
Reda Alhajj